In a groundbreaking study, scientists have discovered more than 100 new human viruses in 252 different gut microbes, ...

When Sean Fletcher walked into Sam Biswas' Medical and Molecular Sciences (MMSC) lab at the University of Delaware College of ...

Scientists at La Trobe University have discovered a previously unknown way viruses could spread around the body, potentially ...

They disable our defenses and hijack the cellular machinery in order to multiply successfully. For example, the herpes simplex virus 1, which causes blister-like skin rashes, and influenza viruses ...

A new drug called lenacapavir might entirely change the game, though.

Abstract: In the field of electronic information equipment, the package reliability of power semiconductor devices plays a key role in the use of products. However, the traditional optimized design ...

Harnessing the power of AI, a research team at the MRC-University of Glasgow Center for Virus Research has launched Viro3D—the most comprehensive database of human and animal virus protein structure ...

A team of researchers from Stanford University and the Arc Institute in Palo Alto, California say they’ve created viruses with AI-designed DNA that can target and kill specific bacteria. And these ...

At the age of 25, Neil Young’s recognisable personality traits—blunt, cynical, uncompromising, dryly funny—were already firmly established in his interactions with the media. He was absolutely ...

Efficient intercellular viral spread is critical for pathogenesis and virulence. In a study published in Science Bulletin, researchers from Peking University Health Science Center and Harbin ...

Ninja Gaiden 4, the first mainline entry in the series in 13 years, is set to release on October 21, 2025. The game is co-developed by Team Ninja and PlatinumGames, the studio known for NieR: Automata ...

First allogeneic T-Cell therapy BLA offers hope to EBV+ PTLD patients who have limited treatment options and lifespan measured in only a few weeks to months following failure of initial treatment EBV+ ...